Perrigo Company plc $PRGO Shares Sold by Monaco Asset Management SAM

Monaco Asset Management SAM decreased its holdings in Perrigo Company plc (NYSE:PRGO) by 42.9% in the fourth quarter, Holdings Channel reports. The fund owned 100,000 shares of the company’s stock after selling 75,000 shares during the period. Monaco Asset Management SAM’s holdings in Perrigo were worth $1,392,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Bahl & Gaynor Inc. increased its holdings in shares of Perrigo by 5.4% during the 3rd quarter. Bahl & Gaynor Inc. now owns 2,087,075 shares of the company’s stock worth $46,479,000 after buying an additional 107,774 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of Perrigo by 1,495.6% during the 4th quarter. SG Americas Securities LLC now owns 134,433 shares of the company’s stock worth $1,871,000 after buying an additional 126,008 shares during the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Perrigo by 8.6% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,797,746 shares of the company’s stock worth $40,036,000 after buying an additional 142,363 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Perrigo by 7.9% during the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock worth $208,568,000 after buying an additional 1,101,154 shares during the last quarter. Finally, Sound Income Strategies LLC increased its holdings in shares of Perrigo by 58.6% during the 4th quarter. Sound Income Strategies LLC now owns 1,138,357 shares of the company’s stock worth $17,110,000 after buying an additional 420,626 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Stock Performance

NYSE:PRGO opened at $11.03 on Monday. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.59 and a current ratio of 2.72. The stock has a market capitalization of $1.53 billion, a P/E ratio of -0.84, a PEG ratio of 1.30 and a beta of 0.51. The company has a 50 day moving average price of $10.97 and a 200 day moving average price of $12.62. Perrigo Company plc has a fifty-two week low of $9.23 and a fifty-two week high of $28.43.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.04. The firm had revenue of $841.80 million during the quarter, compared to analysts’ expectations of $1.04 billion. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The firm’s quarterly revenue was down 7.2% on a year-over-year basis. During the same quarter last year, the company posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts forecast that Perrigo Company plc will post 2.12 EPS for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Friday, May 29th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, May 29th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.5%. Perrigo’s dividend payout ratio (DPR) is presently -8.85%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PRGO. Weiss Ratings downgraded shares of Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Canaccord Genuity Group cut their price target on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a report on Friday, February 27th. Finally, Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $19.33.

More Perrigo News

Here are the key news stories impacting Perrigo this week:

• Positive Sentiment: Zacks Research raised its estimates for Perrigo’s Q3 2026, Q4 2026, Q2 2027, and Q4 2027 earnings, suggesting some expected improvement in later periods. Perrigo estimate updates
• Neutral Sentiment: The analyst kept a Hold rating on Perrigo, indicating no major change in overall stance despite the forecast revisions. Perrigo estimate updates
• Negative Sentiment: Zacks Research cut estimates for Q2 2026, Q1 2027, Q3 2027, FY2026, FY2027, FY2028, and Q1 2028, signaling a weaker near-term and medium-term earnings outlook. Perrigo estimate cuts
• Negative Sentiment: Perrigo’s most recent results showed revenue below expectations and sales down year over year, which can weigh on investor sentiment even though EPS came in ahead of estimates. Perrigo earnings results

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.